Affiliation:
1. Federal University of Vale do São Francisco (UNIVASF)
2. Pernambuco University
3. Federal University of Alagoas (UFAL)
4. Federal University of Sergipe (UFS)
Abstract
Abstract
Background
The COVID-19 pandemic has affected health services around the world. As a result, the control of endemic infectious diseases has been significantly hampered. This study aimed to quantify the impact of the COVID-19 pandemic on quality indicators of leprosy services in Brazil in 2020 and 2021.
Methods
This is an ecological study with 3 indicators: 1- Proportion of new leprosy cases with degree of physical disability assessed at diagnosis; 2- Proportion of contacts of new cases examined; 3- Proportion of leprosy cured among new cases. To determine the impact, the percentage of variation was used, taking into account the values of the indicators expected for 2020 and 2021, using the average of the last five years, and the values observed in the same years. The impact was quantified as a percentage.
Results
Brazil's performance in the three indicators analyzed was considered regular (between ≥ 75% and 89.9%), both in the pre-pandemic period and in the first two years. In the assessment of the degree of physical disability, the number of countries with a proportion greater than 90% decreased from 11 (expected value) to 7 (in 2020) and 9 (in 2021). In the evaluation of contacts, four states were expected to achieve the target (> 90%), but only three achieved the indicator in 2020 and one in 2021 (Tocantins). As for the cure rate, four states were expected to achieve values above 90%, but only three did so in 2020 and two in 2021.
Conclusion
The study showed a negative impact on the quality indicators of leprosy services in Brazil, which was more pronounced in 2021 (for contact examination and cure indicators) than in 2020, making it even more difficult to control the disease in the country.
Publisher
Research Square Platform LLC
Reference36 articles.
1. Penna GO, Pontes MA, de Nobre A, Pinto ML. LF. Pesquisa Nacional de Saúde revela alto percentual de sinais e sintomas de hanseníase no Brasil. Ciênc saúde coletiva [Internet]. 2022Jun;27(6):2255–8. https://doi.org/10.1590/1413-81232022276.18322021.
2. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Diretrizes para vigilância, atenção e eliminação da Hanseníase como problema de saúde pública: manual técnico-operacional [recurso eletrônico]. – Brasília: Ministério da Saúde., 2016. 58 p [citado 29 de janeiro de 2023]. Disponível em: https://portal.saude.pe.gov.br/sites/portal.saude.pe.gov.br/files/diretrizes_para_._eliminacao_hanseniase_-_manual_-_3fev16_isbn_nucom_final_2.pdf.
3. World Health Organization. Global leprosy (Hansen disease) update, 2021: moving towards interruption of transmission. Weekly Epidemiological Record. 2022; (36):429–450. Citado em: 11 out. 2023. Disponível em: https://www.who.int/publications/i/item/who-wer9736-429-450.
4. de Souza CDF, Luna CF, de Magalhães M. AFM. Transmissão da hanseníase na Bahia, 2001–2015: modelagem a partir de regressão por pontos de inflexão e estatística de varredura espacial. Epidemiol Serv Saúde [Internet]. 2019;28(1):e2018065. https://doi.org/10.5123/S1679-49742019000100015.
5. World Health Organization. World Health Assembly. Elimination of leprosy: resolution of the 44th World Health Assembly. Geneva: World Health Organization; 1991. (WHA 44/1991/REC/9).